Abstract
Obesity has become a significant public health problem in the United States and has been associated with significant morbidity and mortality. Alterations in gastrointestinal sensory-motor function are now recognized to be associated with obesity and may be the cause of functional gastrointestinal symptoms commonly seen in these patients. The gut peptides are intimately involved in this process and may provide attractive therapeutic targets in the fight against this very morbid disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
